-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Author Archive: Jason Corum
Five international biotech countries to watch
Scientific American released their third annual WorldView: A Global Biotechnology Perspective at the 2011 BIO International Convention which includes a Bio Innovation Scorecard. The Scorecard reviews individual country biotechnology programs and policies aimed at growing local innovative biotechnology sectors. Based on the results of the Bio Innovation Scorecard, here’s our list of 5 biotechs to watch: 5. Malaysia: Ranking third in the world for the best Enterprise Support of its biotech industry by Scientific American’s Read More >
Innovative China: Policies for the Future
As the second largest and fastest growing market for biotechnology products, China needs no introduction. The opportunity to heal, fuel, and feed 1.3 billion global citizens stands in clear contrast with the regulatory, financial, and political frameworks that present challenges to the life science industry’s external access to the evolving Chinese market. On Tuesday at the 2011 BIO International Convention, a panel discussion titled “Innovative China: Policies for the Future” addressed the future of the Read More >
A Center for Advancing Translational Science can spur new therapies
Sometimes, spurring the development of new drugs and therapies can be like trying to a cross shark-infested water without a bridge, Dr. Francis Collins, director of NIH, said during his keynote at the Translational Research Forum during the 2011 BIO International Convention. However, during a time of unprecedented scientific advances, but increasingly limited resources, the public and private sectors must learn to combine their respective efforts to relieve human suffering. Dr. Collins gave a rapid Read More >
Health
Leave a comment
Email This Post
Tags: 2011 BIO International Convention, American Clean Energy and Security Act, BIO International Convention, Cures Acceleration Network, FDA, Food and Drug Administration, National Center for Advancing Translational Science, National Institute of Health, NIH, Phase Zero, translational research
Tags: 2011 BIO International Convention, American Clean Energy and Security Act, BIO International Convention, Cures Acceleration Network, FDA, Food and Drug Administration, National Center for Advancing Translational Science, National Institute of Health, NIH, Phase Zero, translational research
Broadcasting live from the 2011 BIO International Convention exhibition floor
If you find yourself meandering through the Canadian Pavillion on the 2011 BIO International Convention exhibition floor, keep your eyes peeled for the man with the funny looking microphone sitting behind a bright red laptop. Stop to chat with Mike Spear, from Genome Alberta, and you might end up streaming live on BIORadio. During the convention, Mike is live streaming a radio show available on the Genome Alberta homepage. When the Canadian Pavilion opens, he Read More >
Biotech and the deficit: CNBC interview at the 2011 BIO International Convention
As budget talks aimed at raising the federal debt ceiling move to the presidential level this week, CNBC came to the 2011 BIO International Convention to interview BIO President and CEO Jim Greenwood about the role biotech can play in lowering the U.S. budget deficit. “There are 10,000 baby boomers entering Medicare every day. What if fewer of them were sick? What if fewer of them had cardiovascular disease and cancer and Alzheimer’s and diabetes?” Read More >




